Greenleaf Trust Portfolio holdings
Greenleaf Trust is a privately held, trust-only bank that manages wealth and administers trusts for families. Bill Johnston started it in 1998 after national banks had swallowed up many regional and community banks, wanting a locally owned firm with fiduciary expertise that would serve families across generations. Johnston had already launched a sister firm, Greenleaf Asset Management, in 1991, and the two merged in 2002. The bank builds portfolios around what matters most to each client, whether personal, family-focused or charitable, and avoids selling its own proprietary products. It opened a separate bank, Greenleaf Trust Delaware, in 2018.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NYLIM Merger Arbitrage ETF
MNA
|
+$25.4M |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$10.5M |
| 3 |
Berkshire Hathaway Class B
BRK.B
|
+$3.38M |
| 4 |
Meta Platforms (Facebook)
META
|
+$2.43M |
| 5 |
Booking.com
BKNG
|
+$2.18M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Stryker
SYK
|
+$58M |
| 2 |
Wendy's
WEN
|
+$4.54M |
| 3 |
Steelcase
SCS
|
+$3.95M |
| 4 |
State Street Energy Select Sector SPDR ETF
XLE
|
+$3.89M |
| 5 |
Arch Capital
ACGL
|
+$3.06M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 75.12% |
| 2 | Miscellaneous | 13.67% |
| 3 | Technology | 2.64% |
| 4 | Financials | 2.49% |
| 5 | Consumer Discretionary | 1.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
1
Stryker
SYK
$122B
| $4.03B | 72.95% |
22,736,832
-339,540
| -1% | -$58M |
2013 Q2
21 quarters
|
|
|
2
iShares Core S&P 500 ETF
IVV
$866B
| $415M | 7.5% |
1,416,939
+36,735
| +3% | +$10.5M |
2013 Q2
21 quarters
|
|
3
iShares Core S&P Mid-Cap ETF
IJH
$124B
| $78.2M | 1.41% |
1,942,435
+18,935
| +1% | +$761K |
2013 Q2
21 quarters
|
|
4
iShares Core S&P Small-Cap ETF
IJR
$106B
| $60.1M | 1.09% |
688,440
-18,939
| -3% | -$1.66M |
2013 Q2
21 quarters
|
|
|
5
NYLIM Merger Arbitrage ETF
MNA
$275M
| $31.8M | 0.58% |
1,002,199
+810,438
| +423% | +$25.4M |
2018 Q2
1 quarter
|
|
6
Apple
AAPL
$5.05T
| $31.6M | 0.57% |
560,160
-25,760
| -4% | -$1.34M |
2013 Q2
21 quarters
|
|
7
iShares S&P 500 Growth ETF
IVW
$72.7B
| $20.5M | 0.37% |
463,404
-4,128
| -0.9% | -$177K |
2013 Q2
21 quarters
|
|
8
Visa
V
$789B
| $20.2M | 0.36% |
134,305
+4,456
| +3% | +$634K |
2013 Q2
21 quarters
|
|
9
Alphabet (Google) Class C
GOOG
$3.5T
| $19.5M | 0.35% |
327,040
+740
| +0.2% | +$44.3K |
2013 Q2
21 quarters
|
|
10
Microsoft
MSFT
$4.04T
| $18.6M | 0.34% |
162,739
+10,225
| +7% | +$1.11M |
2013 Q2
21 quarters
|
|
11
iShares MSCI EAFE ETF
EFA
$77B
| $18.5M | 0.33% |
272,194
+3,249
| +1% | +$219K |
2013 Q2
21 quarters
|
|
12
iShares S&P 500 Value ETF
IVE
$51B
| $15.4M | 0.28% |
133,368
-13
| -0% | -$1.49K |
2013 Q2
21 quarters
|
|
13
Honeywell
HON
$72.1B
| $14M | 0.25% |
93,053
-493
| -0.5% | -$69.9K |
2013 Q2
21 quarters
|
|
|
14
Berkshire Hathaway Class B
BRK.B
$1.23T
| $13.3M | 0.24% |
62,181
+16,485
| +36% | +$3.38M |
2013 Q2
21 quarters
|
|
15
PepsiCo
PEP
$195B
| $12.5M | 0.23% |
112,087
+64
| +0.1% | +$7.25K |
2013 Q2
21 quarters
|
|
16
Sherwin-Williams
SHW
$85.7B
| $12.4M | 0.22% |
81,726
-3,048
| -4% | -$451K |
2015 Q2
13 quarters
|
|
17
PayPal
PYPL
$48.8B
| $12.2M | 0.22% |
139,349
-320
| -0.2% | -$28.2K |
2015 Q3
12 quarters
|
|
18
Citigroup
C
$202B
| $11.7M | 0.21% |
163,625
+11,475
| +8% | +$811K |
2016 Q3
8 quarters
|
|
19
Amazon
AMZN
$2.91T
| $11.5M | 0.21% |
114,620
+7,940
| +7% | +$747K |
2016 Q3
8 quarters
|
|
20
Salesforce
CRM
$175B
| $11.4M | 0.21% |
71,665
-3,282
| -4% | -$487K |
2016 Q4
7 quarters
|
|
21
Roper Technologies
ROP
$46.7B
| $11.3M | 0.2% |
38,158
-710
| -2% | -$209K |
2016 Q3
8 quarters
|
|
|
22
Meta Platforms (Facebook)
META
$1.63T
| $11.1M | 0.2% |
67,487
+13,449
| +25% | +$2.43M |
2016 Q3
8 quarters
|
|
23
Pfizer
PFE
$166B
| $11.1M | 0.2% |
264,465
+26,086
| +11% | +$1M |
2013 Q2
21 quarters
|
|
24
iShares MSCI Emerging Markets ETF
EEM
$28B
| $10.9M | 0.2% |
254,638
-452
| -0.2% | -$19.5K |
2015 Q3
12 quarters
|
|
25
Edwards Lifesciences
EW
$59.5B
| $10.6M | 0.19% |
182,436
-5,460
| -3% | -$267K |
2016 Q1
10 quarters
|
|
Similar funds
Greenleaf Trust's Q3 2018 Portfolio in Review
As of Q3 2018, Greenleaf Trust held 570 positions worth $5.53B, up 5.3% from $5.25B the previous quarter. Its ten largest holdings account for 86% of the portfolio.
Greenleaf Trust's Q3 2018 filing shows 57 new, 252 increased, 151 reduced and 39 closed positions. Its largest new stake was ASPEN TECHNOLOGY INC: 6,257 shares worth $713K. The largest sale was Stryker, an estimated $58M.
By sector, the portfolio is most concentrated in Healthcare at 75% of assets, down from 76% a quarter earlier, followed by Miscellaneous and Technology.
- Greenleaf Trust's largest Q3 2018 buy was ASPEN TECHNOLOGY INC: 6,257 shares worth $713K.
- Greenleaf Trust added most to NYLIM Merger Arbitrage ETF in Q3 2018, an estimated $25.4M increase.
- Greenleaf Trust's biggest Q3 2018 reduction was Stryker, cutting an estimated $58M.
- Greenleaf Trust fully exited Arch Capital in Q3 2018, selling an estimated $3.06M.
- Greenleaf Trust's ten largest holdings make up 86% of its $5.53B portfolio in Q3 2018.
- Greenleaf Trust opened 57 new positions and closed 39 in Q3 2018.
- Greenleaf Trust's portfolio value rose 5.3% quarter-over-quarter to $5.53B.
Based on Greenleaf Trust's 13F filing for Q3 2018, filed 29 Oct 2018.